Oscar Health Stock Surges 16.51% Amid Key Updates
By ATTN Desk · Editorial oversight: Sean Han
Introduction
Oscar Health, Inc. (NYSE: OSCR) is a technology-driven health insurer headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, the company aims to make healthcare accessible and affordable for its members through a full-stack digital platform and personalized care teams. As of June 19, 2025, the stock closed at $18.77, reflecting a 16.51% increase on a volume of 49.6 million shares.
Corporate Structure
Oscar Health operates as a public company in the insurance industry with a workforce of approximately 1,001–5,000 employees. The company’s organizational model integrates insurance underwriting with its Oscar Medical Group, which includes care guides, virtual clinicians, and in-person primary care providers in selected states. Key corporate details are summarized below:
| Aspect | Details |
|---|---|
| Founded | 2012 |
| Headquarters | New York, New York |
| Employees | 1,001–5,000 |
| Exchange | NYSE |
| Ticker | OSCR |
Recent Developments and News
On May 7, 2025, Oscar Health filed a Current Report on Form 8-K (Items 2.02 and 9.01) notifying investors of material agreements and updates to its board governance. On May 12, 2025, the company opened applications for its 2025 Culturally Competent Care Grant, offering two $30,000 donations to organizations serving Spanish-speaking individuals and women over 45. Applications were due June 13, 2025.
On May 8, 2025, Oscar Health submitted its Quarterly Report on Form 10-Q for the period ended March 31, 2025, providing insight into membership growth and operating performance. In an 8-K filed on June 6, 2025 (Item 5.07), the company outlined updates regarding its virtual care offerings and partnerships.
LinkedIn updates in June 2025 highlighted the launch of the Clinical Intake Bot, a generative AI tool designed to collect symptom context from members prior to clinician consultations. Oscar Health was also included in the Fortune 500 list for the first time in June 2025, ranking among the notable companies in the “Healthcare, Insurance, and Managed Care” category.
Financial and Strategic Analysis
According to Yahoo Finance data as of June 16, 2025, Oscar Health’s trailing twelve-month revenue reached $10.08 billion, with net income of $123.3 million and diluted EPS of $0.40. The company's market capitalization was reported at $3.69 billion, with a trailing P/E ratio of 36.2 and a forward P/E ratio of 19.6. Key balance-sheet metrics included $2.99 billion in cash and a debt-to-equity ratio of 26.9%.
Oscar Health continues to invest in technology and member engagement, as evidenced by 44% of members interacting digitally with their accounts. Strategic initiatives focus on expanding Oscar Primary Care into new states, enhancing partnerships with providers, and leveraging AI to streamline administrative workflows.
Market Position and Industry Context
Oscar Health competes in the highly regulated U.S. health insurance market, offering individual, small-group, and Medicare Advantage plans. With approximately 1.6 million members nationwide, the company’s technology-driven approach distinguishes it from traditional insurers. Key industry trends include the increasing adoption of Individual Coverage Health Reimbursement Arrangements (ICHRAs)—reported as up 34% among large employers and 52% among small businesses in 2025—and the growing role of telemedicine and generative AI in patient engagement.
Oscar’s member-focused model, supported by dedicated care teams and digital tools, addresses cost transparency and operational challenges within the industry. Its inclusion in the Fortune 500 highlights the company’s operational scale and intent to expand into new markets and product lines.
TL;DR
On June 19, 2025, Oscar Health’s stock rose 16.51% to $18.77 amid high trading volume. In May 2025, the company filed an 8-K updating virtual care partnerships, submitted its Q1 2025 results on Form 10-Q, launched a grant program, and introduced the Clinical Intake Bot AI tool. Oscar Health entered the Fortune 500 in June 2025 and reported trailing twelve-month revenue of $10.08 billion with a market cap of $3.69 billion. The next earnings window is scheduled for August 5–11, 2025, as the company continues expanding its technology-driven healthcare platform.